Sign Up Today and Learn More About Modern Meadow Stock
Invest in or calculate the value of your shares in Modern Meadow or other pre-IPO companies through EquityZen's platform.
![Modern Meadow](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/modernmeadow_logo-7bfc4162ae47ac29.jpg)
Modern Meadow Stock
Biofabricating a revolution in materials for consumers
About Modern Meadow Stock
Founded
2011
Headquarters
Brooklyn, NY, US
Total Funding
53.5M
Industries
Software, Science and Engineering, Consumer Goods
Modern Meadow is developing fundamentally new approaches to growing animal products. This includes cultured leather and meat products which require no animal slaughter and much lower inputs of land, water, energy and chemicals.
Modern Meadow Press Mentions
Stay in the know about the latest news on Modern Meadow
Data snapshot: Tracking a decade of growth in Bioenergy & Biomaterials, the top-funded agrifoodtech category of 2023
agfundernews • Jun 26, 2024
Modern Meadow Announces Sale of its Beauty and Biomedical Applications and Appoints New President/Chief Operating Officer and Executive Chair
prnewswire • Jun 04, 2024
Modern Meadow on LinkedIn: #biovera #nextgenmaterials #circularity #biofabrication #animalfree
linkedin • May 23, 2024
Modern Meadow on LinkedIn: #biovera #nextgenmaterials #circularity #biofabrication
linkedin • May 23, 2024
HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications
prnewswire • May 06, 2024
Investors in Modern Meadow
Discover investors in Modern Meadow stock and explore their portfolio companies
Modern Meadow Management
Leadership team at Modern Meadow
Co-founder & Chief Scientific Officer
Gabor Forgacs
Co-Founder & CEO
Andras Forgacs
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Modern Meadow current valuation
- Modern Meadow stock price
- Available deals in Modern Meadow and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Modern Meadow stock?
Accredited investors can buy pre-IPO stock in companies like Modern Meadow through EquityZen funds. These investments are made available by existing Modern Meadow shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Modern Meadow stock?
Shareholders can sell their Modern Meadow stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."